ERBB2 and neoplasm: A review concluded that PD-L1 expression was heterogeneous and generally associated with the presence of tumor-infiltrating lymphocytes and poor prognostic factors, such as young age, high tumor grade, ER-negativity, PR-negativity, and HER-2 overexpression [49].